Inhibrx to secure $40 mln
Viking Global Investors has agreed to provide $40 million to La Jolla, California-based Inhibrx, a biotech firm. Evercore was financial adviser to Inhibrx on the deal.
22 May 2019•1 min read
Viking Global Investors has agreed to provide $40 million to La Jolla, California-based Inhibrx, a biotech firm. Evercore was financial adviser to Inhibrx on the deal.
